Cozaar and Peg-intron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cozaar (losartan potassium) and Peg-intron (peginterferon alfa-2b). Common drug interactions include infection among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Cozaar and Peg-intron. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Cozaar?

Cozaar has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 45,124 Cozaar users. Check the latest studies of Cozaar.

What is Peg-intron?

Peg-intron has active ingredients of peginterferon alfa-2b. eHealthMe is studying from 11,142 Peg-intron users. Check the latest studies of Peg-intron.

On Jul, 13, 2026

23 people who take Cozaar and Peg-intron together, and have interactions are studied.

Cozaar and Peg-intron drug interactions.

What are the common drug interactions of Cozaar and Peg-Intron, by gender? *:

female:

Infection
Injection site cellulitis (injection site inflammation)
Iris disorder
Joint injury
Joint stiffness
Knee arthroplasty
Lymphadenopathy (disease or enlargement of lymph nodes)
Lymphadenopathy mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs)
Multiple myeloma (cancer of the plasma cells)
Muscle spasms (muscle contraction)

male:

Nausea (feeling of having an urge to vomit)
Decreased appetite
Pain
Pain in extremity
Pitting oedema (skin discoloration)
Seroma (a tumour like collection of serum in the tissues)
Staphylococcal infection (an infection with staphylococcus bacteria)
Arthralgia (joint pain)
Chills (felling of cold)
Erythema (redness of the skin)

What are the common drug interactions of Cozaar and Peg-Intron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anaemia (lack of blood)
Blindness unilateral
Headache (pain in head)
Oedema (fluid collection in tissue)
Optic disc disorder (disease of optic disc of eye)
Pupillary disorder (disorder of the pupil of eyes)
Retinal exudates (discharge from retina)
Retinopathy (acute damage to the retina of the eye)

40-49:

Retinopathy (acute damage to the retina of the eye)
Vision blurred

50-59:

Skin induration (an abnormally hard spot or area on the skin)
Skin ulcer
Staphylococcal abscess (pus formation due to staphylococcal bacteria)
Visual acuity reduced (reduced clearness of vision)
Vomiting
Nausea (feeling of having an urge to vomit)
Decreased appetite
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Weight decreased
Anaemia (lack of blood)

60+:

Headache (pain in head)
Anaemia (lack of blood)
Chest pain
Chills (felling of cold)
Coagulopathy (blood's ability to clot is impaired)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dehydration (dryness resulting from the removal of water)
Dizziness
Dyskinesia (abnormality or impairment of voluntary movement)
Eating disorder

What are the existing conditions these people have? *

Hepatitis C: 20 people, 86.96%

* Approximation only. Some reports may have incomplete information.

Do you take Cozaar and Peg-intron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously